SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
Mirror Image
mokelumne river
From: Strong Long4/12/2016 4:22:05 PM
2 Recommendations  Read Replies (2) of 2026
 
I emailed IR yesterday to try to get updated information about the Sandoz Germany situation. I have not received a response thus far...I'll update if that changes. I also tried to search for any info online that could shed some light to no avail. I did, however, find this interesting article on the EU Public Assessment Report and Scientific Discussion for Vitaros approval in the EU.

On page 6, there is a list of things that were to be monitored post approval, triggered by concern with 3 out of specification batches of Vitaros during early manufacturing. I am guessing that, Sandoz has reacted to a concern with one or more of the items listed..,

If you get bored, there is some very interesting details and facts about Vitaros to be had throughout the 20 some odd pages of narrative in the Public Assessment Report and Scientific Discussion.

db.cbg-meb.nl
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News